Evidence map›Paper›PMID 25889969›Full record

ArticleMicrobial cell factories2015

Cultivation strategies for production of (R)-3-hydroxybutyric acid from simultaneous consumption of glucose, xylose and arabinose by Escherichia coli.

Johan Jarmander, Jaroslav Belotserkovsky, Gustav Sjöberg, Mónica Guevara-Martínez, Mariel Pérez-Zabaleta, Jorge Quillaguamán, Gen Larsson

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Johan JarmanderSchool of Biotechnology, Division of Industrial Biotechnology, KTH Royal Institute of Technology, SE 106 91, Stockholm, Sweden. johanjar@kth.se.
Jaroslav BelotserkovskySchool of Biotechnology, Division of Industrial Biotechnology, KTH Royal Institute of Technology, SE 106 91, Stockholm, Sweden. jarosl@kth.se.
Gustav SjöbergSchool of Biotechnology, Division of Industrial Biotechnology, KTH Royal Institute of Technology, SE 106 91, Stockholm, Sweden. gustavsj@kth.se.
Mónica Guevara-MartínezSchool of Biotechnology, Division of Industrial Biotechnology, KTH Royal Institute of Technology, SE 106 91, Stockholm, Sweden. mguevara@kth.se.
Mariel Pérez-ZabaletaSchool of Biotechnology, Division of Industrial Biotechnology, KTH Royal Institute of Technology, SE 106 91, Stockholm, Sweden. mnpz@kth.se.
Jorge QuillaguamánCenter of Biotechnology, Faculty of Science and Technology, Universidad Mayor de San Simón, Cochabamba, Bolivia. jorgeqs@supernet.com.bo.
Gen LarssonSchool of Biotechnology, Division of Industrial Biotechnology, KTH Royal Institute of Technology, SE 106 91, Stockholm, Sweden. gen@kth.se.
KTH Royal Institute of Technology · SEUniversity of San Simón · BO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLignocellulosic waste is a desirable biomass for use in second generation biorefineries. Up to 40% of its sugar content consist of pentoses, which organisms either take up sequentially after glucose depletion, or not at all. A previously described Escherichia coli strain, PPA652ara, capable of simultaneous consumption of glucose, xylose and arabinose was in the present work utilized for production of (R)-3-hydroxybutyric acid (3HB) from a mixture of glucose, xylose and arabinose.

resultsThe Halomonas boliviensis genes for 3HB production were for the first time cloned into E. coli PPA652ara, leading to product secretion directly into the medium. Process design was based on comparisons of batch, fed-batch and continuous cultivation, where both excess and limitation of the carbon mixture was studied. Carbon limitation resulted in low specific productivity of 3HB (<2 mg g(-1) h(-1)) compared to carbon excess (25 mg g(-1) h(-1)), but the yield of 3HB/cell dry weight (Y3HB/CDW) was very low (0.06 g g(-1)) during excess. Nitrogen-exhausted conditions could be used to sustain a high specific productivity (31 mg g(-1) h(-1)) and to increase the yield of 3HB/cell dry weight to 1.38 g g(-1). Nitrogen-limited fed-batch process design led to further increased specific productivity (38 mg g(-1) h(-1)) but also to additional cell growth (Y3HB/CDW=0.16 g g(-1)). Strain PPA652ara did under all processing conditions simultaneously consume glucose, xylose and arabinose, which was not the case for a reference wild type E. coli, which also gave a higher carbon flux to acetic acid.

conclusionsIt was demonstrated that by using E. coli PPA652ara, it was possible to design a production process for 3HB from a mixture of glucose, xylose and arabinose where all sugars were consumed. An industrial 3HB production process is proposed to be divided into a growth and a production phase, and nitrogen depletion/limitation is a potential strategy to maximize the yield of 3HB/CDW in the latter. The specific productivity of 3HB reported here from glucose, xylose and arabinose by E. coli is further comparable to the current state of the art for production from glucose sources.

Indexed as

3-Hydroxybutyric AcidAcetyl-CoA C-AcetyltransferaseAlcohol OxidoreductasesArabinoseBacterial ProteinsBiomassBioreactorsChromatography, GasEscherichia coliGlucoseHalomonasMetabolic EngineeringReproducibility of ResultsXylose3-Hydroxybutyric Acidacetoacetyl-CoA reductaseAcetyl-CoA C-AcetyltransferaseAlcohol OxidoreductasesArabinoseBacterial ProteinsGlucoseXylose

Identifiers

PMID25889969
PMCPMC4405896
OpenAlexW2158412738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.